BCLPX | EMACX | BCLPX / EMACX | |
Total Expense Ratio | 2.28 | 2.62 | 87% |
Annual Report Gross Expense Ratio | 2.37 | 2.62 | 90% |
Fund Existence | 18 years | 24 years | - |
Gain YTD | 3.726 | 5.442 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.56B | 48.4M | 9,413% |
Annual Yield % from dividends | 0.70 | 0.00 | - |
Returns for 1 year | 4.73 | 10.22 | 46% |
Returns for 3 years | 9.72 | 12.45 | 78% |
Returns for 5 years | 7.08 | 15.66 | 45% |
Returns for 10 years | -37.03 | 8.00 | -463% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNSX | 63.21 | -0.41 | -0.64% |
Janus Henderson Global Life Sciences S | |||
ZDIVX | 26.26 | -0.22 | -0.83% |
Zacks Dividend Investor | |||
GAFFX | 78.34 | -0.95 | -1.20% |
American Funds Growth Fund of Amer F3 | |||
FDCGX | 80.93 | -1.13 | -1.38% |
Fidelity Advisor Consumer Staples C | |||
GGZPX | 22.40 | -0.32 | -1.41% |
Goldman Sachs Enhanced U.S. Equity P |